Evidence map›Paper›PMID 23104807›Full record

ArticleJournal of bacteriology2013

Characterization of a mazEF toxin-antitoxin homologue from Staphylococcus equorum.

Christopher F Schuster, Jung-Ho Park, Marcel Prax, Alexander Herbig, Kay Nieselt, Ralf Rosenstein, Masayori Inouye, Ralph Bertram

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. MazEF Homologs inToxins · 2024
    Article
  3. Frontiers in cellular and infection microbiology · 2021
    Article
  4. Conserved Amino Acid Moieties ofFrontiers in microbiology · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Frontiers in microbiology · 2018
    Article
  11. Artificial Activation ofFrontiers in microbiology · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Christopher F SchusterDepartment of Microbial Genetics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Faculty of Science, University of Tübingen, Tübingen, Germany.
Jung-Ho Park
Marcel Prax
Alexander Herbig
Kay Nieselt
Ralf Rosenstein
Masayori Inouye
Ralph Bertram
University of Tübingen · DEJohnson University · US

Funding

Deciphering of the Toxin-Antitoxin Systems in E. coliR01GM081567 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI INOUYE, MASAYORI · 2009 to 2012
$1.8M
NIGMS NIH HHS 1R01-GM 081567NIGMS NIH HHS R01 GM081567
6 · The paper itself

Abstract

Toxin-antitoxin (TA) systems encoded in prokaryotic genomes fall into five types, typically composed of two distinct small molecules, an endotoxic protein and a cis-encoded antitoxin of ribonucleic or proteinaceous nature. In silico analysis revealed seven putative type I and three putative type II TA systems in the genome of the nonpathogenic species strain Staphylococcus equorum SE3. Among these, a MazEF system orthologue termed MazEF(seq) was further characterized. 5' rapid amplification of cDNA ends (RACE) revealed the expression and the transcriptional start site of mazE(seq), indicating an immediately upstream promoter. Heterologous expression of the putative toxin-encoding mazF(seq) gene imposed growth cessation but not cell death on Escherichia coli. In vivo and in vitro, MazF(seq) was shown to cleave at UACAU motifs, which are remarkably abundant in a number of putative metabolic and regulatory S. equorum gene transcripts. Specific interaction between MazF(seq) and the putative cognate antitoxin MazE(seq) was demonstrated by bacterial two-hybrid analyses. These data strongly suggest that MazEF(seq) represents the first characterized TA system in a nonpathogenic Staphylococcus species and indicate that MazEF modules in staphylococci may also control processes beyond pathogenicity.

Indexed as

Amino Acid SequenceAntitoxinsBacterial ProteinsBacterial ToxinsBase SequenceEscherichia coliGene Expression Regulation, BacterialGenome, BacterialMolecular Sequence DataRNA, BacterialRNA, MessengerStaphylococcusAntitoxinsBacterial ProteinsBacterial ToxinsRNA, BacterialRNA, Messenger

Identifiers

PMID23104807
PMCPMC3536171
OpenAlexW2141093488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.